Cessation

Researchers who are willing to push back on the mantra of giving primacy to "FDA authorised smoking cessation treatments" and going with evidence of public health impact as the basis for their conclusions.
Results: Smokers reporting ENDS use for cigarette cessation were more likely to be abstinent at one-year follow-up (Odds Ratio[OR] = 1.62, 95% CI: 1.06-2.49, P =.03) as well as quit using non-cigarette tobacco products (OR = 2.11, 95% CI: 1.65-2.70, P <.001) than those reporting ENDS use for alternative reasons.
Conclusions: Current tobacco users are recommended to use FDA-approved products for smoking cessation, such as nicotine replacement therapy. However, given the high prevalence of cigarette use among military populations, ENDS may provide a useful alternative harm reduction strategy for this high-risk population.
PDF Version
- Aycock CA, Wang XQ, Williams JB, Fahey MC, Talcott GW, Klesges RC, Little MA.Prev Med Rep. 2023 Sep 8;35:102399. doi: 10.1016/j.pmedr.2023.102399. eCollection 2023 Oct. PMID: 37712011

TBD

36% of study participants falsely believed vaping was as harmful as smoking.
- Citation: Devika Dixit, Ellen Herbst, Smita Das, E-Cigarette Use and Perceptions Among Veterans Receiving Outpatient Treatment in Veterans Affairs Substance Use and Mental Health Clinics, Military Medicine, Volume 186, Issue 1-2, January-February 2021, Pages 24–29, https://doi.org/10.1093/milmed/usaa292
  - Acknowledgement: This was funded by 2016 APA SAMHSA Substance Abuse Fellowship, Smita Das, MD, PhD, MPH (no number associated).